| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1210/EDRV-9-2-181 |
| P698 | PubMed publication ID | 3042375 |
| P2093 | author name string | Wilson JD | |
| P433 | issue | 2 | |
| P304 | page(s) | 181-199 | |
| P577 | publication date | 1988-05-01 | |
| P1433 | published in | Endocrine Reviews | Q3054007 |
| P1476 | title | Androgen abuse by athletes | |
| P478 | volume | 9 |
| Q36258057 | 7 Testicular steroidogenesis and androgen use and abuse |
| Q28378401 | A report on alterations to the speaking and singing voices of four women following hormonal therapy with virilizing agents |
| Q30409171 | Adverse health consequences of performance-enhancing drugs: an Endocrine Society scientific statement |
| Q34098584 | Adverse health effects of anabolic-androgenic steroids |
| Q41611286 | Alterations in diaphragm contractility after nandrolone administration: an analysis of potential mechanisms |
| Q44334151 | Anabolic androgenic steroids affects alcohol intake, defensive behaviors and brain opioid peptides in the rat. |
| Q60180035 | Anabolic androgenic steroids increase beta-endorphin levels in the ventral tegmental area in the male rat brain |
| Q73179499 | Anabolic steroid and gender-dependent modulation of cytosolic HSP70s in fast- and slow-twitch skeletal muscle |
| Q42014734 | Anabolic steroid induced hypogonadism treated with human chorionic gonadotropin |
| Q34264601 | Anabolic steroid use among students at a British college of technology |
| Q34233913 | Anabolic steroid use in the adolescent athlete |
| Q70618538 | Anabolic steroids |
| Q73016893 | Anabolic steroids and lymphocyte function in sedentary and exercise-trained rats |
| Q37982627 | Anabolic steroids--a review of the clinical toxicology and diagnostic screening |
| Q44796283 | Anabolic-androgenic steroid abuse and performance-enhancing drugs among adolescents. |
| Q52053103 | Anabolic-androgenic steroid and adrenal steroid effects on hippocampal plasticity |
| Q46075788 | Anabolic-androgenic steroid does not enhance compensatory muscle hypertrophy but significantly diminish muscle damages in the rat surgical ablation model |
| Q73343911 | Anabolic-androgenic steroid induced alterations in choline acetyltransferase messenger RNA levels of spinal cord motoneurons in the male rat |
| Q60180032 | Anabolic-androgenic steroids affect the content of substance P and substance P(1-7) in the rat brain |
| Q40448776 | Anabolic-androgenic steroids. Current issues. |
| Q33642471 | Androgen abuse: the price of growth and performance |
| Q33607522 | Androgen deficiency and aging in men. |
| Q37141801 | Androgen deficiency: effects on body composition |
| Q35197853 | Androgen effects on body composition |
| Q33637738 | Androgen effects on body composition and muscle function: implications for the use of androgens as anabolic agents in sarcopenic states |
| Q36721461 | Androgen inhibits abdominal fat accumulation and negatively regulates the PCK1 gene in male chickens |
| Q42949657 | Androgen receptor signaling induced by supraphysiological doses of dihydrotestosterone in human peripheral blood lymphocytes. |
| Q40870969 | Androgen replacement therapy |
| Q35871132 | Androgen replacement therapy: present and future |
| Q58248183 | Androgens and cardiovascular disease in men and women |
| Q34277230 | At what price, glory? Severe cholestasis and acute renal failure in an athlete abusing stanozolol. |
| Q33739880 | Atrial fibrillation and anabolic steroids |
| Q57423582 | Avaliação descritiva sobre o uso de esteroides anabolizantes e seu efeito sobre as variáveis bioquímicas e neuroendócrinas em indivíduos que praticam exercício resistido |
| Q35541519 | Behavioral and physiological responses to anabolic-androgenic steroids |
| Q45095303 | Beyond performance enhancement: polypharmacy among collegiate users of steroids |
| Q33778748 | Can androgen therapy replete lean body mass and improve muscle function in wasting associated with human immunodeficiency virus infection? |
| Q36736118 | Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement |
| Q37216994 | Clinical Assessment and Urine Testing for Anabolic-Androgenic Steroid Abuse and Dependence |
| Q35624509 | Diagnosis and treatment of sexual dysfunctions in late-onset hypogonadism |
| Q28566261 | Dihydrotestosterone and estrogen regulation of rat brain androgen-receptor immunoreactivity |
| Q35149807 | Effect of androgens on the brain and other organs during development and aging |
| Q69652639 | Effect of extended use of single anabolic steroids on urinary steroid excretion and metabolism |
| Q36786751 | Effect of supraphysiological dose of Nandrolone Decanoate on the testis and testosterone concentration in mature and immature male rats: A time course study |
| Q44185330 | Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. |
| Q68095385 | Effects of anabolic steroids and high intensity exercise on rat skeletal muscle fibres and capillarization. A morphometric study |
| Q35049342 | Effects of anabolic steroids and high-intensity aerobic exercise on skeletal muscle of transgenic mice |
| Q33979780 | Effects of androgenic-anabolic steroids in athletes |
| Q44371402 | Effects of nandrolone on acute morphine responses, tolerance and dependence in mice |
| Q77917193 | Endocrine aspects of ageing in the male |
| Q28273389 | Endocrine effects in female weight lifters who self-administer testosterone and anabolic steroids |
| Q82029928 | Endocrine myopathies |
| Q38744671 | Epidemiological and policy issues in the measurement of the long term health effects of anabolic-androgenic steroids |
| Q36258074 | Evaluation of testicular function |
| Q37481427 | Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse |
| Q28245725 | Gynaecomastia--pathophysiology, diagnosis and treatment |
| Q35846060 | Hidden Danger of Irrational Abusing Illegal Androgenic-anabolic Steroids in Recreational Athletes Age Under 35 in Bosnia & Herzegovina |
| Q71662984 | Hormonal regulation of skeletal muscle hypertrophy in rats: the testosterone to cortisol ratio |
| Q34679013 | Human chorionic gonadotrophin and sport |
| Q61451405 | Hyperhomocysteinemia in bodybuilders taking anabolic steroids |
| Q38261724 | Male central hypogonadism secondary to exogenous androgens: a review of the drugs and protocols highlighted by the online community of users for prevention and/or mitigation of adverse effects |
| Q46234985 | Microbial oxidation of anabolic steroids. |
| Q38383101 | Molecular effects of supraphysiological doses of doping agents on health |
| Q41466777 | Muscle-bound? A tissue-selective nonsteroidal androgen receptor modulator |
| Q28111974 | Muscular strength, body composition and health responses to the use of testosterone enanthate: a double blind study |
| Q34069603 | Myocytic androgen receptor controls the strength but not the mass of limb muscles |
| Q84583168 | Novel strategies for improving physical function |
| Q70636648 | Oxandrolone in constitutional delay of growth: analysis of the growth patterns up to final stature |
| Q44877873 | Oxymetholone modulates cell-mediated immunity in male B6C3F1 mice |
| Q24650695 | Pharmacology of anabolic steroids |
| Q38067480 | Physiology, pathology and pharmacology of the male reproductive system |
| Q33637793 | Potential adverse effects of long-term testosterone therapy |
| Q74608055 | Potential for the effects of anabolic steroid abuse in the immune and neuroendocrine axis |
| Q34234033 | Prevalence of anabolic steroid use among illinois high school students |
| Q36381250 | Protein chips for high-throughput doping screening in athletes |
| Q37980103 | Psychiatric effects of androgenic and anabolic-androgenic steroid abuse in men: a brief review of the literature |
| Q38013627 | Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review |
| Q48882290 | Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use |
| Q77416048 | Rank dependent seasonal levels of IGF-1, cortisol and reproductive hormones in male pudu (Pudu puda) |
| Q40859841 | Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations |
| Q38031403 | Recent developments in the toxicology of anabolic steroids |
| Q28611237 | Regulation of androgen action |
| Q35667540 | Regulation of body composition by androgens |
| Q37125927 | Regulation of myogenic differentiation by androgens: cross talk between androgen receptor/ beta-catenin and follistatin/transforming growth factor-beta signaling pathways |
| Q35671734 | Resistance training associated with the administration of anabolic-androgenic steroids improves insulin sensitivity in ovariectomized rats. |
| Q34565492 | Roles of androgens in the development, growth, and carcinogenesis of the mammary gland |
| Q24679317 | Some rewarding effects of androgens may be mediated by actions of its 5alpha-reduced metabolite 3alpha-androstanediol |
| Q52528643 | Stanozolol, oxymetholone, and testosterone cypionate effects on the rat estrous cycle. |
| Q48085402 | Study of body composition, lung function, and quality of life following use of anabolic steroids in patients with chronic obstructive pulmonary disease |
| Q34626441 | Supplements and drugs used to enhance athletic performance |
| Q71751118 | Testosterone deficiency myopathy |
| Q36921614 | Testosterone differentially alters cocaine-induced ambulatory and rearing behavioral responses in adult and adolescent rats |
| Q34457503 | Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors |
| Q89440879 | Testosterone, myocardial function, and mortality |
| Q44387353 | Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. |
| Q24658011 | The benefits and risks of testosterone replacement therapy: a review |
| Q77151286 | The cardiac toxicity of anabolic steroids |
| Q28271250 | The effect of anabolic-androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area |
| Q52523997 | The effects of 17 alpha-methyltestosterone, methandrostenolone, and nandrolone decanoate on the rat estrous cycle. |
| Q71219997 | The effects of anabolic androgenic steroids on serum ubiquinone and dolichol levels among steroid abusers |
| Q37022008 | The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings. |
| Q35873973 | The efficacy of ergogenic agents in athletic competition. Part I: Androgenic-anabolic steroids |
| Q40799965 | The future of doping control in athletes. Issues related to blood sampling |
| Q35611154 | The mechanisms of androgen effects on body composition: mesenchymal pluripotent cell as the target of androgen action |
| Q44176727 | The nucleus accumbens as a site of action for rewarding properties of testosterone and its 5alpha-reduced metabolites |
| Q37018360 | Treating Steroid Abuse: A Psychiatric Perspective |
| Q38947622 | Up-to-Date Applications of Microarrays and Their Way to Commercialization |
| Q28252561 | Update on nandrolone and norsteroids: how endogenous or xenobiotic are these substances? |
| Q72079787 | Urine excretion of androgen hormones in professional racing cyclists |
| Q35986847 | Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study |
| Q73772959 | [43 cycles of anabolic steroid treatment studied in athletes: the uses and secondary effects] |
Search more.